Index of reports
> Cases with Breast Cancer in Situ (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mustargen (Mechlorethamine) where reactions include breast cancer in situ. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Mustargen side effects in 42 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31
Patient: 42 year old female
Reactions: Atrial Septal Defect, Fatigue, Hypoxia, Breast Cancer in Situ, Fibrosis, Exercise Tolerance Decreased
Drug(s) suspected as cause:
Mustargen
Other drugs received by patient: Thyroid TAB; Lexapro (Escitalopram Ocalate); Calcium / Vitamin D (Lekovit CA); Levothyroxine Sodium
|